Lundbeck's Asedebart Receives FDA Orphan Drug Designation for Cushing's Syndrome #Denmark #Lundbeck #Valby #Cushing's_Syndrome #asedebart
@newsen.bsky.social
@newsen.bsky.socialLundbeck's Asedebart Receives FDA Orphan Drug Designation for Cushing's Syndrome #Denmark #Lundbeck #Valby #Cushing's_Syndrome #asedebart
@newsen.bsky.socialLundbeck's Asedebart Receives Orphan Drug Status for Rare Hormonal Disorder #USA #Lundbeck #Valby #Cushing's_Syndrome #asedebart